Romain Dambre

Other noteworthy experience

Advising:

Private equity firms, financial sponsors, SPACs and family offices, including Advent, Altaris, Apax, Blackstone, Carlyle, EQT, Greenbriar, MacAndrews & Forbes, Ridgemont Equity Partners, and their portfolio companies, in acquisitions and divestitures

Public and private companies in their domestic and cross-border strategic transactions, including:

• Celanese in its $1.15 billion acquisition of ExxonMobil’s Santoprene global business
• Charter Communications in its streaming joint venture with Comcast
• Eli Lilly in its acquisition of Protomer Technologies for a transaction value of over $1.0 billion (previous law firm experience)
• Equity One in its $15.6 billion merger of equals with Regency Centers
• Fortive Corporation in its $2 billion acquisition of Accruent
• Huntsman in its proposed $20 billion merger of equals with Clariant
• Infineon Technologies in its $10.1 billion acquisition of Cypress Semiconductor
• Micro Focus in its $8.8 billion acquisition of Hewlett Packard Enterprise’s global software business
• Travelport Worldwide in its $4.4 billion sale to affiliates of Elliott Management and Siris Capital
• WellCare Health Plans in its $17.3 billion sale to Centene

Published work

• “Initial Coin Offerings and U.S. Securities Regulation: Challenges and Perspectives,” 1 Int’l J. Fin. Serv. 9 (2018)
• Equity Derivatives: French and EU Corporate Law Aspects (Larcier eds., 1st ed. 2016, 527 pp.) (in French)
• “Hedging by Corporate Executives: Three Regulatory Models,” 1/2 Rev. Trim. Dr. Fin. 59 (2015) (in French)
• “A Transalpine Look at Equity Derivatives: Convergence and Divergence in Disclosure and Takeover Regulations in the EU,” 3 Rev. Trim. Dr. Fin. 64 (2012) (with Marco Dell’Erba)